BB
Bhavesh Bansidhar Pujara
About Bhavesh Bansidhar Pujara
Data last updated:
Bhavesh Bansidhar Pujara is a Cfo at La Renon Healthcare Private Limited (since 2026), Nominee Director at Enaltec Labs Private Limited (since 2025) and Nominee Director at Enaltec Pharma Research Private Limited (since 2026), and holds 2 more current directorships. The companies operate in Pharma. The 5 current companies with reported revenue have a combined latest revenue of ₹1,866 Cr; the largest is La Renon Healthcare Private Limited at ₹1,686 Cr (FY 2025). Earlier, Bhavesh Bansidhar Pujara was a Cfo at Alivus Life Sciences Limited (2020–2022) and Cfo at Hetero Labs Limited (2022–2025) and 3 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 La Renon Healthcare Private Limited U24233GJ2007PTC051467 | Cfo | 14 Jul 2026 | 2007 | ₹1,686 Cr (FY 2025) | Active |
 Enaltec Labs Private Limited U21001MH2006PTC160020 | Nominee Director | 30 Dec 2025 | 2006 | ₹170 Cr (FY 2025) | Active |
| Enaltec Pharma Research Private Limited U24230MH2005PTC153404 | Nominee Director | 25 Feb 2026 | 2005 | ₹5.67 Cr (FY 2025) | Active |
 Hetero Plasma Sciences Private Limited U46497TS2023PTC175917 | Director | 10 Aug 2023 | 2023 | ₹4.83 Cr (FY 2025) | Active |
 Rusoma Healthcare Private Limited U85300MP2021PTC057356 | Nominee Director | 07 Jan 2026 | 2021 | ₹14.8 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Alivus Life Sciences Limited L74900PN2011PLC139963 | Cfo | 01 Dec 2020 | 2011 | ₹2,421 Cr (FY 2025) | Active |
| Hetero Labs Limited U24110TG1989PLC009723 | Cfo | 17 Nov 2022 | 1989 | ₹16,537 Cr (FY 2025) | Active |
| Hetero Biopharma Limited U24290TG2016PLC111946 | Additional Director | 14 Jun 2024 | 2016 | ₹387 Cr (FY 2024) | Active |
| Actero Pharma Private Limited U24304TG2016PTC111055 | Additional Director | 31 Mar 2025 | 2016 | Active | |
| Aspiro Pharma Specialities Private Limited U24299TG2020PTC143320 | Director | 13 Nov 2024 | 2020 | ₹6.9 Lakh (FY 2025) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Bhavesh Bansidhar Pujara
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhavesh Bansidhar Pujara
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhavesh Bansidhar Pujara
Bhavesh Bansidhar Pujara currently holds 5 directorships: La Renon Healthcare Private Limited (Cfo, since 14 Jul 2026, revenue ₹1,686 Cr (FY 2025)); Enaltec Labs Private Limited (Nominee Director, since 30 Dec 2025, revenue ₹170 Cr (FY 2025)); Enaltec Pharma Research Private Limited (Nominee Director, since 25 Feb 2026, revenue ₹5.67 Cr (FY 2025)); Hetero Plasma Sciences Private Limited (Director, since 10 Aug 2023, revenue ₹4.83 Cr (FY 2025)); Rusoma Healthcare Private Limited (Nominee Director, since 07 Jan 2026, revenue ₹14.8 Lakh (FY 2025)).
Bhavesh Bansidhar Pujara was first appointed on 01 Dec 2020 as Cfo at Alivus Life Sciences Limited. The most recent appointment on record is 14 Jul 2026 at La Renon Healthcare Private Limited.
The 5 current companies of Bhavesh Bansidhar Pujara that report revenue have a combined latest revenue of ₹1,866 Cr: La Renon Healthcare Private Limited ₹1,686 Cr (FY 2025); Enaltec Labs Private Limited ₹170 Cr (FY 2025); Enaltec Pharma Research Private Limited ₹5.67 Cr (FY 2025); Hetero Plasma Sciences Private Limited ₹4.83 Cr (FY 2025); Rusoma Healthcare Private Limited ₹14.8 Lakh (FY 2025).
Bhavesh Bansidhar Pujara held 5 earlier board appointments: Alivus Life Sciences Limited (Cfo, 01 Dec 2020 to 22 Apr 2022); Hetero Labs Limited (Cfo, 17 Nov 2022 to 10 Oct 2025); Hetero Biopharma Limited (Additional Director, 14 Jun 2024 to 18 Sep 2024); Actero Pharma Private Limited (Additional Director, 31 Mar 2025 to 04 Sep 2025); Aspiro Pharma Specialities Private Limited (Director, from 13 Nov 2024).
The current boards of Bhavesh Bansidhar Pujara's companies include Anshul Agarwal (La Renon Healthcare Private Limited), Bharadwaj Thiruvenkata Venkatavaraghavan (La Renon Healthcare Private Limited), Bharat Singh (La Renon Healthcare Private Limited), Krunal Akshaykumar Shah (La Renon Healthcare Private Limited), Kshitij Pankaj Sheth (La Renon Healthcare Private Limited), Nihit Duggal (La Renon Healthcare Private Limited), among others.